Post-authorisation safety studies

They must concern regulatory approved products used in approved indications and can include, but not only, non-interventional trials, observational trials, post-marketing surveillance and post-authorisation safety studies. 

A lack of proactive and proportionate monitoring including a lack of risk management and structured data collection in the form of post authorisation safety studies. 

---